Uploaded July 2025 | Updated September 2026, 2 weeks ago

---

In this episode, Jenn Krohn from Gilead Sciences explains how centralized monitoring helps uncover issues like underreported adverse events by comparing data across all study sites – something traditional review methods often miss.

This broader view supports better decision-making, improves data quality, and strengthens patient safety. Jenn also discusses how open-source tools, AI, and cross-functional collaboration are shaping the future of risk-based quality management.